Cytomx Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Cytomx Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.0k | 1.3k | 1.55 |
2023-09-30 | $1.7k | 1.3k | 1.29 |
2023-06-30 | $2.2k | 1.3k | 1.72 |
2022-03-31 | $180k | 67k | 2.67 |
2021-12-31 | $290k | 67k | 4.33 |
2021-09-30 | $346k | 68k | 5.09 |
2021-06-30 | $406k | 64k | 6.33 |
2021-03-31 | $471k | 61k | 7.72 |
2020-12-31 | $387k | 59k | 6.54 |
2020-09-30 | $371k | 56k | 6.65 |
2020-06-30 | $530k | 64k | 8.33 |
2020-03-31 | $465k | 61k | 7.67 |
2019-12-31 | $518k | 62k | 8.31 |
2019-09-30 | $452k | 61k | 7.38 |
2019-06-30 | $676k | 60k | 11.21 |
2019-03-31 | $621k | 58k | 10.75 |
2018-12-31 | $893k | 59k | 15.10 |
2018-09-30 | $698k | 38k | 18.49 |
2018-06-30 | $847k | 37k | 22.86 |
2018-03-31 | $824k | 29k | 28.46 |
2017-12-31 | $607k | 29k | 21.11 |
2017-09-30 | $600k | 33k | 18.18 |
2017-06-30 | $504k | 33k | 15.50 |
2017-03-31 | $378k | 22k | 17.25 |
2016-12-31 | $231k | 21k | 10.98 |
2016-09-30 | $270k | 17k | 15.67 |
2016-06-30 | $152k | 15k | 10.18 |